Bioethics in Perspective: Corporate Power, Public Health and Political Economy
In Bioethics in Perspective Scott Mann demonstrates the importance of issues of corporate power, global inequality and sustainability in shaping health outcomes around the world. The text develops a comprehensive ethical and practical critique of the neoliberal economic ideas which have guided policy in the English-speaking world. It explores the consequences of such policies for health and healthcare around the world, in terms of increasing health inequalities, serious food and water shortages, inadequate health care provision and the marketing of dangerous and unnecessary drugs. With clear proposals for political and economic reform to effectively address these problems, Bioethics in Perspective provides an important counterbalance to much conventional commentary on bioethics. It takes readers with little or no prior knowledge of ethics, economics or medicine quickly and easily into advanced debates and discussions about the causes and consequences of health and illness around the world.
What people are saying - Write a review
We haven't found any reviews in the usual places.
agricultural allowed animals antibiotic resistance antibiotics argue Australia banks beneﬁts capital carbon Chang and Grabel Chapter competition conﬂict consumers contributed corporate costs countries developing world Diesendorf difﬁcult disease drug companies economic effective efﬁcient emissions energy ethical exports farmers farming ﬁnance ﬁnancial ﬁnd ﬁrms ﬁrst ﬁve ﬂow fossil fuels free market funds gene genetic global warming GM crops greenhouse gas health outcomes hedge funds herbicide human ideas identiﬁed ideologies income increased individuals industry inequality inﬂation investment involved issues justiﬁed labour land levels liberal major Maslin massive Mehrotra and Delamonica million monopoly moral neoliberal organisations output particular patents peak oil plants political pollution poorer population privatisation problems production proﬁts protection rates reduced risk sacriﬁce scientiﬁc sector signiﬁcant signiﬁcantly social speciﬁc technologies trade transgenic utilitarian welfare World Bank